Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Geusens

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
BMC Musculoskeletal Disorders|January 7, 2017
A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritisPiet Geusens, Karel Pavelka, Jozef Rovensky, et al.
Journal of Evaluation in Clinical Practice|September 11, 2007
The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guidelineSvenhjalmar van Helden, Evelyne Cauberg, Piet Geusens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 28, 2008
Impact of systematic implementation of a clinical case finding strategy on diagnosis and therapy of postmenopausal osteoporosisPiet Geusens, Bianca Dumitrescu, Tineke van Geel, et al.
Arthritis and Rheumatism|February 5, 2005
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)Désirée van der Heijde, Ben Dijkmans, Piet Geusens, et al.
The American Journal of Sports Medicine|November 19, 2003
Factors affecting bone loss in female endurance athletes: a two-year follow-up studyLavienja A J L M Braam, Marjo H J Knapen, Piet Geusens, et al.
Journal of Neuroimmunology|April 18, 2002
Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?Mieke Buntinx, Marcel Ameloot, Paul Steels, et al.
Joint Bone Spine|March 5, 2013
Prospective assessment of bone texture parameters at the hand in rheumatoid arthritisLaetitia Sparsa, Sami Kolta, Karine Briot, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risksTjeerd-Peter van Staa, John A Kanis, Piet Geusens, et al.
Rheumatology and Therapy|May 4, 2020
Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic DiseasesHermine Leroi, Valérie Badot, Filip De Keyser, et al.
Bone|October 27, 2019
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trialDavid L Kendler, Fernando Marin, Piet Geusens, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
BMC Musculoskeletal Disorders|January 7, 2017
A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritisPiet Geusens, Karel Pavelka, Jozef Rovensky, et al.
Journal of Evaluation in Clinical Practice|September 11, 2007
The fracture and osteoporosis outpatient clinic: an effective strategy for improving implementation of an osteoporosis guidelineSvenhjalmar van Helden, Evelyne Cauberg, Piet Geusens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 28, 2008
Impact of systematic implementation of a clinical case finding strategy on diagnosis and therapy of postmenopausal osteoporosisPiet Geusens, Bianca Dumitrescu, Tineke van Geel, et al.
Arthritis and Rheumatism|February 5, 2005
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT)Désirée van der Heijde, Ben Dijkmans, Piet Geusens, et al.
The American Journal of Sports Medicine|November 19, 2003
Factors affecting bone loss in female endurance athletes: a two-year follow-up studyLavienja A J L M Braam, Marjo H J Knapen, Piet Geusens, et al.
Journal of Neuroimmunology|April 18, 2002
Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?Mieke Buntinx, Marcel Ameloot, Paul Steels, et al.
Joint Bone Spine|March 5, 2013
Prospective assessment of bone texture parameters at the hand in rheumatoid arthritisLaetitia Sparsa, Sami Kolta, Karine Briot, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risksTjeerd-Peter van Staa, John A Kanis, Piet Geusens, et al.
Rheumatology and Therapy|May 4, 2020
Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic DiseasesHermine Leroi, Valérie Badot, Filip De Keyser, et al.
Bone|October 27, 2019
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trialDavid L Kendler, Fernando Marin, Piet Geusens, et al.
Pageof 15